Patent Expiry

Patent/Exclusivity Expiry: EKTERLY

January 26, 2039

Company: KalVista Pharmaceuticals, Inc. (KALV)
Drug: EKTERLY

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: EKTERLY — KALV Patent Expiry | BioSniper